Revista Colombiana de Cancerologia最新文献_第10页

Necesitamos menos investigación! 我们需要更少的研究！

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-05-26 DOI: 10.35509/01239015.700

Jairo Echeverry

引用次数: 0

Pandemia de la covid19 y cáncer en el Instituto Nacional de Cancerología –ESE: Cómo actuar pronto y seguro 国家癌症研究所的新冠病毒大流行与癌症-ESE：如何迅速安全地采取行动

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-05-25 DOI: 10.35509/01239015.698

Sonia Isabel Cuervo Maldonado

引用次数: 1

Consenso del Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL) para el manejo del Linfoma en estado de Pandemia SARS CoV-2 / COVID 19 拉丁美洲淋巴增生性研究小组(GELL)对SARS CoV-2 / COVID - 19大流行状态下淋巴瘤管理的共识

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-05-22 DOI: 10.35509/01239015.690

Juan Alejandro Ospina Idárraga, Humberto Martínez-Cordero, Henry Idrobo Quintero, Conrad Ortiz Alfaro, Lina María Martínez Correa, J. García, Luis Malpica, J. Castillo, M. A. Torres, L. Villela, Myrna G Candelaria, Alana Von Glasenapp, B. Beltrán, Sally Paredes, D. E. Castro, Virginia Prates, Marcos Di Stefano, E. Riva, Virginia Abello Polo, Juan Choque, Camila Peña, Christine Rojas, Fabiola Valvert Gamboa, Lorena Fiad

{"title":"Consenso del Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL) para el manejo del Linfoma en estado de Pandemia SARS CoV-2 / COVID 19","authors":"Juan Alejandro Ospina Idárraga, Humberto Martínez-Cordero, Henry Idrobo Quintero, Conrad Ortiz Alfaro, Lina María Martínez Correa, J. García, Luis Malpica, J. Castillo, M. A. Torres, L. Villela, Myrna G Candelaria, Alana Von Glasenapp, B. Beltrán, Sally Paredes, D. E. Castro, Virginia Prates, Marcos Di Stefano, E. Riva, Virginia Abello Polo, Juan Choque, Camila Peña, Christine Rojas, Fabiola Valvert Gamboa, Lorena Fiad","doi":"10.35509/01239015.690","DOIUrl":"https://doi.org/10.35509/01239015.690","url":null,"abstract":"In December 2019, the cause of COVID-19 disease, SARS-CoV2 virus was detected for the first time in China. The virus spread quickly through Europe and Asia, and a couple months after arrived Latin America. Elderly patients and those with chronic disease, including cancer, have high risk of mortatily because of COVID-19. Consequently, many doubts arise in the group of health professionals in charge of cancer treatment during the pandemic because they must handle risk-benefit of providing treatment to patients who are at the base with an increased risk for manifestations derived from COVID-19. In this consensus we propose recommendations for hematology professionals who provide treatment to patients with any type of lymphoma, looking to clarify the clinical picture during the pandemic","PeriodicalId":42496,"journal":{"name":"Revista Colombiana de Cancerologia","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42668065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 5

Consenso del Grupo Latinoamericano de estudio de Mieloma Múltiple (MM) GELAMM para el manejo del MM en estado de Pandemia SARS CoV-2 / COVID 19 拉丁美洲多发性骨髓瘤(MM)研究小组GELAMM对SARS CoV-2 / COVID - 19大流行状态下MM管理的共识

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-05-22 DOI: 10.35509/01239015.656

Humberto Martinez-Codero, L. Martínez, Juan Alejandro Ospina Idárraga, Guillermo J Ruiz Argüelles, Virginia Abello Polo, Camila Peña Ojeda, Macarena Roa, Carlos Fernández de Larrea, Rosa Olday Ríos Jiménez, D. Fantl, Natalia Schutz, E. Riva, Fiorella Villano, Henry Idrobo, V. Bove, Manuel Antonio Granja Morá, M. Zamora

{"title":"Consenso del Grupo Latinoamericano de estudio de Mieloma Múltiple (MM) GELAMM para el manejo del MM en estado de Pandemia SARS CoV-2 / COVID 19","authors":"Humberto Martinez-Codero, L. Martínez, Juan Alejandro Ospina Idárraga, Guillermo J Ruiz Argüelles, Virginia Abello Polo, Camila Peña Ojeda, Macarena Roa, Carlos Fernández de Larrea, Rosa Olday Ríos Jiménez, D. Fantl, Natalia Schutz, E. Riva, Fiorella Villano, Henry Idrobo, V. Bove, Manuel Antonio Granja Morá, M. Zamora","doi":"10.35509/01239015.656","DOIUrl":"https://doi.org/10.35509/01239015.656","url":null,"abstract":"COVID-19 disease was detected at the end of 2019 in Wuhan, China. Due it´s quickly spread was declared a health emergency initially and after identifying cases outside China with indigenous transmission, characterized by considerably high mortality in countries such as Italy and Spain, it was declared a pandemic by the World Health Organization. It has been shown that older patients with a history of chronic diseases including cancer develop severe disease, presenting a higher risk of mortality from SARS-CoV2 / COVID-19. This is especially important in the handle of patients with Multiple Myeloma (MM), generating new challenges, improvement and learning opportunities for Medical group, that contribute to the risk-benefit analysis of immunosuppressive treatment for this type of pathology. \u0000The consensus aims to provide guidance for the management of patients with MM in this time where the health professional requires information to carry out efficient therapies in patient care.","PeriodicalId":42496,"journal":{"name":"Revista Colombiana de Cancerologia","volume":" ","pages":""},"PeriodicalIF":0.2,"publicationDate":"2020-05-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46289232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Análisis del uso de fármacos fuera de indicación autorizada en hematología y oncología 血液学和肿瘤学中使用非授权适应症药物的分析

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-03-09 DOI: 10.35509/01239015.32

María Antonia Meroño Saura, M. D. Perez, Francisco Ayala de la Peña, Taida María Rodríguez Martínez, Celia Fernández Zamora, J. L. Villar

{"title":"Análisis del uso de fármacos fuera de indicación autorizada en hematología y oncología","authors":"María Antonia Meroño Saura, M. D. Perez, Francisco Ayala de la Peña, Taida María Rodríguez Martínez, Celia Fernández Zamora, J. L. Villar","doi":"10.35509/01239015.32","DOIUrl":"https://doi.org/10.35509/01239015.32","url":null,"abstract":"Background and objective: the use of off-label drugs is the use of medications in conditions other than those included in its prescribing information. The objective of this paper is to analyze the off-label drugs applications and their results, performed by the Oncology and Hematology services in a second level hospital. \u0000Materials and methods: A retrospective observational study of all requests for \"off label\" drugs received by the Pharmacy Service was carried out. The drugs were classified according to economic impact, a classification according to the type of drug and the reason for the request and according to the degree of evidence. The demographic, diagnostic and treatment data of the patients were analyzed for each request. A follow-up of adverse effects, median progression-free survival and median overall survival is presented. \u0000Results: 85 treatment requests were approved. Most of the treatments were high impact, mainly aimed at rare pathologies and last treatment options. 22% of the requests had a high degree of evidence. Progression free survival (PFS) and overall survival (OS) were 6.6 (95% CI 5.2-8) and 9.7 months (95% CI 8.2-11.2). 18.7% of patients had grade 3-4 toxicity when receiving treatment. \u0000Conclusions: Despite the heterogeneity of the pathologies, and the low evidence, the results obtained in SLP and SG, together with the low toxicity, force us to continue advancing in the evaluation of this type of treatments.","PeriodicalId":42496,"journal":{"name":"Revista Colombiana de Cancerologia","volume":"24 1","pages":"3-10"},"PeriodicalIF":0.2,"publicationDate":"2020-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43981823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

El uso off label de medicamento: ¿buena o mala práctica? 药品标签外使用:好还是坏?

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-03-09 DOI: 10.35509/01239015.421

José Julián López G

引用次数: 0

Resúmenes VI Jornadas investigación 摘要VI研究会议

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-02-19 DOI: 10.35509/01239015.341

Julie Milena Galvis Jiménez

引用次数: 0

Traducción y adaptación transcultural de la escala FACIT-PAL para medir la calidad de vida en pacientes con cáncer avanzado en Colombia 哥伦比亚晚期癌症患者生活质量测量FACIT-PAL量表的翻译和跨文化适应

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-02-13 DOI: 10.35509/01239015.13

Adriana Valdelamar Jiménez, B. Molina, Luisa Rodríguez, Ricardo Sánchez Pedraza

{"title":"Traducción y adaptación transcultural de la escala FACIT-PAL para medir la calidad de vida en pacientes con cáncer avanzado en Colombia","authors":"Adriana Valdelamar Jiménez, B. Molina, Luisa Rodríguez, Ricardo Sánchez Pedraza","doi":"10.35509/01239015.13","DOIUrl":"https://doi.org/10.35509/01239015.13","url":null,"abstract":"Introduction: Measuring quality of life in patients having advanced cancer using scales allows to objectively evaluate a prioritary outcome in this group of patients. \u0000Objective: to translate and adapt the FACIT-Pal scale cross-culturally in patients with advanced cancer in Colombia. \u0000Methods: The study was carried out according to the steps suggested by the FACIT group for translation and transcultural adaptation of scales. A pilot test was applied to 10 Colombian patients who attended the palliative care service of the Instituto Nacional de \u0000 \u0000Cancerologia E.S.E. \u0000Results: in the adaptation the items Pal-1, 5,10,12 and 14 were modified in the reconciled version and there were no changes in the translation of the instructions and answer options; after the pilot test, the items that were confusing for the patients were Pal-5 and 9 and no items were offensive. \u0000Conclusions: A transculturally adapted version of the FACIT-Pal was generated; this version can be validated in patients diagnosed with advanced cancer in Colombia.","PeriodicalId":42496,"journal":{"name":"Revista Colombiana de Cancerologia","volume":"24 1","pages":"18-25"},"PeriodicalIF":0.2,"publicationDate":"2020-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42738308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 3

Diabetes posterior a tratamiento no quirúrgico de un insulinoma maligno: reporte de caso y revisión literatura 恶性胰岛素瘤非手术治疗后的糖尿病：病例报告和文献回顾

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-02-11 DOI: 10.35509/01239015.138

M LuisF.Fierro, C JesúsO.Sánchez, G MireyaTapiero, R AndrésFlórez, D HenryVargas, C ClaudiaCórdoba

引用次数: 0

Etiología de nódulos pulmonares en pacientes con cáncer mamario 乳腺癌患者肺结节的病因

IF 0.2

Revista Colombiana de Cancerologia Pub Date : 2020-02-11 DOI: 10.35509/01239015.81

Carolina Alvarez Tapias, Luis Guzmán, Sandra Díaz, J. Carreño, Rafael Beltrán, Ricardo Buitrago, C. Carvajal

{"title":"Etiología de nódulos pulmonares en pacientes con cáncer mamario","authors":"Carolina Alvarez Tapias, Luis Guzmán, Sandra Díaz, J. Carreño, Rafael Beltrán, Ricardo Buitrago, C. Carvajal","doi":"10.35509/01239015.81","DOIUrl":"https://doi.org/10.35509/01239015.81","url":null,"abstract":"Materials and Methods: A case-series study was developed to describe the clinical, histological and anatomopathological characteristics of a sample of patients with a diagnosis of de novo metastatic breast cancer or whom presented with pulmonary nodules during their disease that required surgical resection by wedge pulmonary or lobectomy in the INC, between January 1, 2015 and April 30, 2018. \u0000Results: Fifty-five cases were included in the study period, of which 26 (47.3%) were breast cancer metastases, 9 (16.4%) were pulmonary primary second, and 1 (1.8%) patient had primary pulmonary cancer and one breast metastasis concomitantly. Another 2 (3.6%) patients had metastases from other organs, one from the rectum and one from the thyroid, while the remaining 17 (30.9%) patients presented a report of benign pulmonary lesions in the pathological anatomy. \u0000Conclusion: The presence of pulmonary nodules in patients with breast cancer are not always secondary to metastatic disease. Other etiologies may exist, such as primary pulmonary cancer, metastasis from other cancers, benign lung tumors or infections. Knowing the etiology of pulmonary nodules in patients with breast cancer is crucial to evaluate the therapeutic options .","PeriodicalId":42496,"journal":{"name":"Revista Colombiana de Cancerologia","volume":"24 1","pages":"11-17"},"PeriodicalIF":0.2,"publicationDate":"2020-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46763633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0